CIK 0002100782 · <br>Emerging growth company
Generate Biomedicines, Inc.
Sign in to watch- Ticker
- GENB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831630228
- Phone
- 888-469-0055
- Business address
- 101 SOUTH STREET, SUITE 900, SOMERVILLE, MA, 02143
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $200,735
- in 2 filings, $201K under 10b5-1 plans
Net −$200,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Nally Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +844,595 | 844,595 | ||
| 2026-02-26 | Bancel Stephane Director | Grant or award · Stock Option (Right to Buy) | +29,561 | 29,561 | ||
| 2026-02-26 | Mendillo Jane L Director | Grant or award · Stock Option (Right to Buy) | +29,561 | 29,561 | ||
| 2026-02-26 | Fanucci Marsha Director | Grant or award · Stock Option (Right to Buy) | +29,561 | 29,561 | ||
| 2026-02-26 | Parker Paul Gray Director | Grant or award · Stock Option (Right to Buy) | +29,561 | 29,561 | ||
| 2026-02-26 | AFEYAN NOUBAR Director | Grant or award · Stock Option (Right to Buy) | +29,561 | 29,561 |
Page 4 of 4 · 66 trades